Shares in Cardica (CRDC) fell of a cliff yesterday as an A.G. Edwards analyst downgraded the stock on muted enthusiasm for its new surgical product. The fellow must feel a bit embarrassed today.
CRDC shares are up over 20% today on news the company "received a key European approval for its new device for connecting blood vessels during heart bypass surgery," according to The Associated Press.
So there.
Douglas A. McIntyre
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
